KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $30,970,000 | -17.2% | 9,108,867 | -8.5% | 0.82% | -21.3% |
| Q2 2018 | $37,412,000 | -5.9% | 9,950,055 | +2.4% | 1.04% | -16.5% |
| Q1 2018 | $39,751,000 | -12.0% | 9,719,176 | 0.0% | 1.25% | -18.1% |
| Q4 2017 | $45,194,000 | +11.3% | 9,719,176 | +69.9% | 1.52% | -4.0% |
| Q3 2017 | $40,606,000 | -1.8% | 5,719,176 | 0.0% | 1.58% | -3.6% |
| Q2 2017 | $41,350,000 | +17.4% | 5,719,176 | 0.0% | 1.64% | +21.8% |
| Q1 2017 | $35,230,000 | +5.1% | 5,719,176 | 0.0% | 1.35% | +9.8% |
| Q4 2016 | $33,514,000 | +10.4% | 5,719,176 | 0.0% | 1.23% | -18.4% |
| Q3 2016 | $30,369,000 | -19.8% | 5,719,176 | 0.0% | 1.51% | -23.8% |
| Q2 2016 | $37,861,000 | +41.8% | 5,719,176 | 0.0% | 1.98% | +56.7% |
| Q1 2016 | $26,709,000 | -3.8% | 5,719,176 | +4.0% | 1.26% | -16.9% |
| Q4 2015 | $27,775,000 | +57.8% | 5,500,000 | +10.0% | 1.52% | +20.6% |
| Q3 2015 | $17,600,000 | – | 5,000,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 25,791,678 | $170,741,000 | 2.32% |
| Abrams Capital Management | 5,719,176 | $37,861,000 | 1.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 562,900 | $3,726,000 | 0.97% |
| Old West Investment Management, LLC | 126,230 | $835,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 450,111 | $2,980,000 | 0.53% |
| Virtus ETF Advisers LLC | 92,536 | $613,000 | 0.46% |
| Knoll Capital Management, LLC | 200,000 | $1,324,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 912,830 | $6,043,000 | 0.35% |
| CLOUGH CAPITAL PARTNERS L P | 879,900 | $5,825,000 | 0.31% |
| Century Capital Management, LLC | 272,773 | $1,806,000 | 0.20% |